These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Long-term, open-label evaluation of the safety and efficacy of telmisartan 80 mg/hydrochlorothiazide 25 mg fixed-dose combination alone or with other antihypertensive medication. Neldam S; Edwards C Expert Opin Pharmacother; 2009 Feb; 10(3):345-52. PubMed ID: 19191674 [TBL] [Abstract][Full Text] [Related]
24. Telmisartan or valsartan alone or in combination with hydrochlorothiazide: a review. Lacourcière Y Clin Exp Hypertens; 2013; 35(1):50-60. PubMed ID: 22866964 [TBL] [Abstract][Full Text] [Related]
25. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring. Lacourcière Y; Neutel JM; Davidai G; Koval S Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201 [TBL] [Abstract][Full Text] [Related]
26. A meta-analysis of randomized head-to-head trials of telmisartan versus other angiotensin II receptor blocker in combination with hydrochlorothiazide for reduction of blood pressure. Takagi H; Mizuno Y; Goto SN; Umemoto T; Int J Cardiol; 2013 Sep; 167(6):3062-5. PubMed ID: 23200265 [No Abstract] [Full Text] [Related]
27. An update on telmisartan/hydrochlorothiazide combinations for the management of hypertensive patients with additional cardiovascular risk factors. Kjeldsen S; Mancia G; Schmieder R; Mattheus M; Unger T Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):673-82. PubMed ID: 23750676 [TBL] [Abstract][Full Text] [Related]
28. Effect of tablets with a combination of telmisartan and amlodipine on patients with hypertension: the Cotalo study. Ohishi M; Kawai T; Hayashi N; Kitano S; Katsuya T; Nagano M; Hirotani A; Yamamoto K; Kamide K; Rakugi H Hypertens Res; 2013 Jul; 36(7):620-6. PubMed ID: 23425955 [TBL] [Abstract][Full Text] [Related]
29. Blood pressure-lowering and antiproteinuric effect of switching from high-dose angiotensin receptor blockers to normal-dose telmisartan and low-dose hydrochlorothiazide in hypertensive patients with chronic kidney disease. Abe M; Okada K; Maruyama T; Matsumoto S; Matsumoto K Int J Clin Pharmacol Ther; 2010 Mar; 48(3):206-13. PubMed ID: 20197015 [TBL] [Abstract][Full Text] [Related]
30. Effectiveness of using long-acting angiotensin II type 1 receptor blocker in Japanese obese patients with metabolic syndrome on morning hypertension monitoring by using telemedicine system (FUJIYAMA study). Kinoshita S; Ryuzaki M; Sone M; Nishida E; Nakamoto H; Clin Exp Hypertens; 2014; 36(7):508-16. PubMed ID: 24433108 [TBL] [Abstract][Full Text] [Related]
31. Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 x 4 factorial study. Littlejohn TW; Majul CR; Olvera R; Seeber M; Kobe M; Guthrie R; Oigman W; Postgrad Med; 2009 Mar; 121(2):5-14. PubMed ID: 19332958 [TBL] [Abstract][Full Text] [Related]
32. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing. Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements. Nishimura T; Hashimoto J; Ohkubo T; Kikuya M; Metoki H; Asayama K; Totsune K; Imai Y Clin Exp Hypertens; 2005 Aug; 27(6):477-89. PubMed ID: 16081340 [TBL] [Abstract][Full Text] [Related]
34. Telmisartan and hydrochlorothiazide combination therapy for the treatment of hypertension. Kjeldsen SE; Schmieder RE; Unger T; Mancia G Curr Med Res Opin; 2010 Apr; 26(4):879-87. PubMed ID: 20144138 [TBL] [Abstract][Full Text] [Related]
35. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements. Kamoi K; Ikarashi T Clin Exp Hypertens; 2005 May; 27(4):369-76. PubMed ID: 15921073 [TBL] [Abstract][Full Text] [Related]
36. A comparative study on the effectiveness of losartan/hydrochlorothiazide and telmisartan/hydrochlorothiazide in patients with hypertension. Hamada T; Kuwabara M; Watanabe A; Mizuta E; Ohtahara A; Omodani H; Watanabe M; Nakamura H; Hirota Y; Miyazaki S; Kato M; Ogino K; Kosaka H; Haruaki N; Taniguchi S; Yamamoto K; Kotake H; Hisatome I Clin Exp Hypertens; 2014; 36(4):251-7. PubMed ID: 23865441 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hermida RC; Ayala DE; Fernández JR; Calvo C Hypertension; 2007 Oct; 50(4):715-22. PubMed ID: 17635851 [TBL] [Abstract][Full Text] [Related]
38. Long-term exposure to telmisartan as monotherapy or combination therapy: efficacy and safety. Freytag F; Holwerda NJ; Karlberg BE; Meinicke TW; Schumacher H Blood Press; 2002; 11(3):173-81. PubMed ID: 12126264 [TBL] [Abstract][Full Text] [Related]
39. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study. Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR; Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of low-dose hydrochlorothiazide in combination with telmisartan on early morning blood pressure in uncontrolled hypertensive patients. Makita S; Abiko A; Naganuma Y; Tamada M; Nakamura M Clin Exp Hypertens; 2009 Apr; 31(2):105-15. PubMed ID: 19330600 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]